As of July 10, 2025, Lexington Biosciences Holdings Corp (LXGTF) reports a Current Ratio of N/A.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Lexington Biosciences Holdings Corp's Current Ratio
Over recent years, Lexington Biosciences Holdings Corp's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2020-12-31 | - |
| 2019-12-31 | 0.01 |
| 2018-12-31 | 0.16 |
| 2017-12-31 | 5.61 |
| 2016-12-31 | 5.00 |
This gradual decrease highlights how Lexington Biosciences Holdings Corp manages its short-term assets and liabilities over time.
Comparing Lexington Biosciences Holdings Corp's Current Ratio to Peers
To better understand Lexington Biosciences Holdings Corp's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Lexington Biosciences Holdings Corp (LXGTF) | - |
| Eviana Health Corp (EHC.CN) | 6.60 |
| Miravant Medical Technologies (MRVT) | 3.45 |
| China Industrial Group Inc (CIND) | 3.31 |
| Terminus Energy Inc (TMGY) | 1.86 |
| NuvusGro Corp (NUVG) | 1.00 |
Compared to its competitors, Lexington Biosciences Holdings Corp's Current Ratio is difficult to compare due to insufficient data.